CRRT for Lactic Acidosis
Bicarbonate-based replacement fluid should be used instead of lactate-based solutions when performing CRRT in patients with lactic acidosis, but CRRT initiation should not be driven by the presence of lactic acidosis alone, as it does not improve mortality and may be associated with worse outcomes.
Key Recommendation on Fluid Composition
When CRRT is indicated for other reasons (e.g., severe AKI with conventional dialysis indications) in patients who also have lactic acidosis:
- Use bicarbonate as the buffer in replacement/dialysate fluids rather than lactate 1
- Lactate-based solutions can worsen acidosis in patients with lactic acidosis or liver failure 1
- This is a grade C recommendation from international consensus guidelines
Critical Evidence on CRRT Initiation for Lactic Acidosis
CRRT should NOT be initiated solely to treat lactic acidosis. The most recent high-quality evidence demonstrates:
- In a 2026 MIMIC-IV database analysis of 4,450 ICU patients with severe lactic acidosis (lactate ≥5 mmol/L), early RRT initiation within 24 hours was associated with increased 90-day mortality (OR 1.51; 95% CI 1.05-2.20) even after adjustment for illness severity 2
- A 2022 single-center study of 1,203 patients with severe lactic acidosis found patients started on RRT had 2.3 times higher odds of mortality versus those who did not receive RRT, even after propensity adjustment 3
- Overall 90-day mortality in severe lactic acidosis ranges from 34.5% to 51.3%, with ICU mortality reaching 83.6% in dialyzed patients 3, 2
When CRRT May Be Appropriate
CRRT should be considered in lactic acidosis patients only when conventional indications for renal replacement therapy are present 1:
- Diuretic-unresponsive pulmonary edema
- Severe hyperkalemia
- Uremic complications
- Severe AKI requiring renal support
- Specific toxin/drug removal (e.g., metformin-associated lactic acidosis with AKI) 4
Management Parameters When CRRT Is Used
Fluid Selection
- Bicarbonate-buffered solutions are mandatory in lactic acidosis 1
- Avoid lactate-containing replacement fluids entirely
- Avoid supraphysiologic glucose concentrations 1
Monitoring Considerations
- The propensity to receive RRT in lactic acidosis is typically driven by lactate level and SOFA renal/cardiac scores 3
- Lactate may stabilize/decrease in 69.7% at 4 hours and 81.8% at 24 hours after CRRT initiation 5
- However, initial lactate concentration does not predict mortality in severe lactic acidosis patients 5
- Avoid volume overload, especially in acute lung injury (grade C) 1
Anticoagulation Caution
- If using regional citrate anticoagulation, severe lactic acidosis (lactate >10 mmol/L) and pH <7.14 predict immediate citrate accumulation 6
- Citrate accumulation carries 97% ICU mortality 6
- Close monitoring of total calcium/ionized calcium ratio (tCa/iCa) is essential if citrate is used
Common Pitfalls to Avoid
Do not initiate CRRT solely to "clear lactate" - this approach is associated with worse outcomes and reflects selection of sicker patients 2, 3
Lactic acidosis is primarily a biomarker of underlying disease severity, not a pathogenic mechanism requiring direct extracorporeal correction 7
Never use lactate-buffered replacement fluids in patients with existing lactic acidosis - this can worsen acidosis 1
Focus on treating the underlying cause of lactic acidosis (sepsis, shock, tissue hypoperfusion) rather than the acidosis itself 7
Avoid aggressive bicarbonate infusions - current evidence does not support this approach for lactic acidosis 7
Clinical Algorithm
For patients with severe lactic acidosis:
- Treat the underlying cause (restore perfusion, treat sepsis, remove offending agents)
- Assess for conventional RRT indications (AKI with uremic complications, volume overload, electrolyte emergencies)
- If RRT is indicated for conventional reasons:
- Use bicarbonate-buffered solutions
- Avoid lactate-containing fluids
- Consider heparin over citrate if lactate >10 mmol/L and pH <7.14
- If no conventional RRT indication exists: supportive care without CRRT, as extracorporeal therapy will not improve outcomes
The evidence strongly suggests that CRRT is a supportive measure for renal failure, not a treatment for lactic acidosis itself.